Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis

扩大残疾状况量表 医学 多发性硬化 危险系数 队列 比例危险模型 疾病 内科学 儿科 精神科 置信区间
作者
Carmen Tur,Pere Carbonell‐Mirabent,Álvaro Cobo‐Calvo,Susana Otero‐Romero,Georgina Arrambide,Luciana Midaglia,Joaquín Castilló,Ángela Vidal‐Jordana,Breogán Rodrı́guez‐Acevedo,Ana Zabalza,Ingrid Galán,Carlos Nos,Annalaura Salerno,Cristina Auger,Deborah Pareto,Manuel Comabella,Jordi Río,Jaume Sastre‐Garriga,Àlex Rovira,Mar Tintoré,Xavier Montalbán
出处
期刊:JAMA Neurology [American Medical Association]
卷期号:80 (2): 151-151 被引量:68
标识
DOI:10.1001/jamaneurol.2022.4655
摘要

Importance Progression independent of relapse activity (PIRA) is the main event responsible for irreversible disability accumulation in relapsing multiple sclerosis (MS). Objective To investigate clinical and neuroimaging predictors of PIRA at the time of the first demyelinating attack and factors associated with long-term clinical outcomes of people who present with PIRA. Design, Setting, and Participants This cohort study, conducted from January 1, 1994, to July 31, 2021, included patients with a first demyelinating attack from multiple sclerosis; patients were recruited from 1 study center in Spain. Patients were excluded if they refused to participate, had alternative diagnoses, did not meet protocol requirements, had inconsistent demographic information, or had less than 3 clinical assessments. Exposures Exposures included (1) clinical and neuroimaging features at the first demyelinating attack and (2) presenting PIRA, ie, confirmed disability accumulation (CDA) in a free-relapse period at any time after symptom onset, within (vs after) the first 5 years of the disease (ie, early/late PIRA), and in the presence (vs absence) of new T2 lesions in the previous 2 years (ie, active/nonactive PIRA). Main Outcomes and Measures Expanded Disability Status Scale (EDSS) yearly increase rates since the first attack and adjusted hazard ratios (HRs) for predictors of time to PIRA and time to EDSS 6.0. Results Of the 1128 patients (mean [SD] age, 32.1 [8.3] years; 781 female individuals [69.2%]) included in the study, 277 (25%) developed 1 or more PIRA events at a median (IQR) follow-up time of 7.2 (4.6-12.4) years (for first PIRA). Of all patients with PIRA, 86 of 277 (31%) developed early PIRA, and 73 of 144 (51%) developed active PIRA. Patients with PIRA were slightly older, had more brain lesions, and were more likely to have oligoclonal bands than those without PIRA. Older age at the first attack was the only predictor of PIRA (HR, 1.43; 95% CI, 1.23-1.65; P < .001 for each older decade). Patients with PIRA had steeper EDSS yearly increase rates (0.18; 95% CI, 0.16-0.20 vs 0.04; 95% CI, 0.02-0.05; P < .001) and an 8-fold greater risk of reaching EDSS 6.0 (HR, 7.93; 95% CI, 2.25-27.96; P = .001) than those without PIRA. Early PIRA had steeper EDSS yearly increase rates than late PIRA (0.31; 95% CI, 0.26-0.35 vs 0.13; 95% CI, 0.10-0.16; P < .001) and a 26-fold greater risk of reaching EDSS 6.0 from the first attack (HR, 26.21; 95% CI, 2.26-303.95; P = .009). Conclusions and Relevance Results of this cohort study suggest that for patients with multiple sclerosis, presenting with PIRA after a first demyelinating event was not uncommon and suggests an unfavorable long-term prognosis, especially if it occurs early in the disease course.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顾矜应助LZR采纳,获得10
刚刚
刚刚
weadu完成签到,获得积分10
1秒前
Li应助板凳儿cc采纳,获得10
2秒前
rym完成签到 ,获得积分10
2秒前
3秒前
超帅鸣凤完成签到,获得积分10
3秒前
ESLG发布了新的文献求助10
3秒前
闪闪路人完成签到,获得积分10
3秒前
4秒前
ACMI完成签到,获得积分10
4秒前
新酱发布了新的文献求助10
4秒前
Sunshine完成签到,获得积分10
5秒前
why完成签到,获得积分10
5秒前
做不了一点科研完成签到 ,获得积分10
5秒前
清爽的冬寒完成签到 ,获得积分10
7秒前
碎落星沉完成签到,获得积分10
7秒前
优雅盼海完成签到,获得积分10
7秒前
7秒前
dx完成签到,获得积分10
7秒前
专注灵凡完成签到,获得积分10
8秒前
Yang完成签到 ,获得积分10
8秒前
高高梦山完成签到 ,获得积分10
8秒前
小魏完成签到,获得积分10
8秒前
728完成签到,获得积分10
9秒前
七子完成签到,获得积分10
9秒前
油麦菜完成签到 ,获得积分10
10秒前
10秒前
小背包完成签到 ,获得积分10
11秒前
zzx396完成签到,获得积分0
11秒前
11秒前
复杂的凝冬完成签到,获得积分10
12秒前
Hello应助科研通管家采纳,获得10
13秒前
debu9完成签到,获得积分10
13秒前
科研通AI5应助科研通管家采纳,获得10
13秒前
故酒应助科研通管家采纳,获得10
13秒前
科研通AI5应助科研通管家采纳,获得10
13秒前
大个应助科研通管家采纳,获得10
13秒前
故酒应助科研通管家采纳,获得10
13秒前
普鲁卡因完成签到,获得积分10
13秒前
高分求助中
Technologies supporting mass customization of apparel: A pilot project 600
Izeltabart tapatansine - AdisInsight 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
Epigenetic Drug Discovery 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3815945
求助须知:如何正确求助?哪些是违规求助? 3359450
关于积分的说明 10402728
捐赠科研通 3077293
什么是DOI,文献DOI怎么找? 1690285
邀请新用户注册赠送积分活动 813693
科研通“疑难数据库(出版商)”最低求助积分说明 767743